|
US3709898A
(en)
|
1971-02-09 |
1973-01-09 |
Upjohn Co |
Process for the production of triazolobenzodiazepines and intermediates
|
|
US3681343A
(en)
|
1971-05-11 |
1972-08-01 |
Upjohn Co |
6-phenyl-s-triazolo{8 4,3-a{9 {8 1,4{9 {0 benzodiazepines
|
|
US3812259A
(en)
|
1971-08-09 |
1974-05-21 |
Upjohn Co |
Animal feed and process
|
|
CH622019A5
(en)
|
1975-10-23 |
1981-03-13 |
Upjohn Co |
Process for the preparation of aminotriazolobenzodiazepines
|
|
FR2329668A1
(fr)
|
1975-10-27 |
1977-05-27 |
Upjohn Co |
Procede de preparation d'aminotriazolobenzodiazepines
|
|
EP0087850A1
(en)
|
1982-01-04 |
1983-09-07 |
The Upjohn Company |
Benzodiazepines for anti-hypertensive use
|
|
DE3435973A1
(de)
|
1984-10-01 |
1986-04-10 |
Boehringer Ingelheim KG, 6507 Ingelheim |
Diazepine enthaltende pharmazeutische zusammensetzungen mit paf-antagonistischer wirkung
|
|
JPS62181282A
(ja)
*
|
1986-01-21 |
1987-08-08 |
ベ−リンガ− インゲルハイム コマンデイツト ゲゼルシヤフト |
チエノ−１，４−ジアゼピン
|
|
DE3778559D1
(de)
*
|
1986-01-21 |
1992-06-04 |
Boehringer Ingelheim Kg |
Thieno-1,4-diazepine.
|
|
DE3724164A1
(de)
|
1986-07-25 |
1988-01-28 |
Boehringer Ingelheim Kg |
Neue 1,4-benzodiazepine, ihre herstellung und verwendung
|
|
EP0315698B1
(en)
|
1987-05-28 |
1993-03-03 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Thieno(triazolo)diazepine compounds and medicinal application of the same
|
|
JPH0676326B2
(ja)
|
1988-05-24 |
1994-09-28 |
吉富製薬株式会社 |
循環器系疾患治療薬
|
|
EP0368175A1
(de)
|
1988-11-06 |
1990-05-16 |
Boehringer Ingelheim Kg |
3S,7S-3-(Morpholinocarbonyl)-5-(2-chlorphenyl)-7,10-dimethyl-3,4-dihydro-2H,7H-cyclopenta[4,5]thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin.
|
|
EP0387613A1
(de)
|
1989-03-03 |
1990-09-19 |
Boehringer Ingelheim Kg |
Neue Thienodiazepine
|
|
YU133090A
(sh)
|
1989-07-12 |
1993-10-20 |
Boehringer Ingelheim Kg. |
Novi heteroazepini s paf-antaganostičnim učinkom in postopek za njihovo pripravo
|
|
DE4010528A1
(de)
|
1990-04-02 |
1991-10-17 |
Boehringer Ingelheim Kg |
Praeparativ chromatographisches trennverfahren zur herstellung enantiomerenreiner hetrazepine
|
|
JP2959591B2
(ja)
*
|
1990-05-23 |
1999-10-06 |
吉富製薬株式会社 |
チエノトリアゾロジアゼピン化合物
|
|
DE4107521A1
(de)
*
|
1991-03-08 |
1992-09-10 |
Boehringer Ingelheim Kg |
Neue acylaminosubstituierte hetrazepine
|
|
EP0638560A4
(en)
|
1991-10-11 |
1995-03-29 |
Yoshitomi Pharmaceutical |
MEDICINE FOR OSTEOPOROSIS AND DIAZEPINE COMPOUND *.
|
|
WO1994006802A1
(fr)
|
1992-09-18 |
1994-03-31 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Compose de thienodiazepine et son utilisation medicinale
|
|
EP0692483A1
(en)
*
|
1993-03-30 |
1996-01-17 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Cell adhesion inhibitor and thienotriazolodiazepine compound
|
|
JP3001979U
(ja)
|
1994-03-14 |
1994-09-06 |
有限会社マルセ木工 |
竿掛け具
|
|
WO1995032963A1
(en)
|
1994-06-01 |
1995-12-07 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Thienylazole compound and thienotriazolodiazepine compound
|
|
DK0801651T3
(da)
|
1995-01-06 |
2001-10-22 |
Hoffmann La Roche |
Hydroxymethyl-imidazodiazepiner og deres estere
|
|
BR9610390A
(pt)
|
1995-09-09 |
1999-07-06 |
Hoffmann La Roche |
O uso de uma tienotriazolodiazepina para aumentar os níveis da apoliproteína a-i
|
|
US5893397A
(en)
|
1996-01-12 |
1999-04-13 |
Bioject Inc. |
Medication vial/syringe liquid-transfer apparatus
|
|
CA2258053A1
(en)
|
1996-06-12 |
1997-12-18 |
Yoshihisa Yamamoto |
Cytokine production inhibitors, triazepine compounds, and intermediates thereof
|
|
US5693641A
(en)
|
1996-08-16 |
1997-12-02 |
Berlex Laboratories Inc. |
Bicyclic pyrimidine derivatives and their use as anti-coagulants
|
|
CN1109037C
(zh)
|
1996-09-13 |
2003-05-21 |
三菱制药株式会社 |
噻吩并－三唑并二氮杂䓬化合物及其医药用途
|
|
US6444664B1
(en)
|
1997-04-18 |
2002-09-03 |
Nederlandse Organisatie Voor Toegepast - Natuurweten Schappelijk Onderzoek (Tno) |
Method for controlling the plasma level of lipoproteins to treat alzheimeris disease
|
|
US5993412A
(en)
|
1997-05-19 |
1999-11-30 |
Bioject, Inc. |
Injection apparatus
|
|
JPH11228576A
(ja)
|
1997-12-10 |
1999-08-24 |
Japan Tobacco Inc |
アポトーシス抑制剤
|
|
FR2779652B1
(fr)
*
|
1998-06-15 |
2001-06-08 |
Sod Conseils Rech Applic |
Utilisation de diazepines pour la preparation de medicaments destines a traiter les etats pathologiques ou les maladies dans lesquels un des recepteurs de la somatostatine est implique
|
|
US7589167B2
(en)
|
2000-02-22 |
2009-09-15 |
J. David Gladstone Institutes |
ZA loops of bromodomains
|
|
WO2001095912A1
(fr)
|
2000-06-16 |
2001-12-20 |
Mitsubishi Pharma Corporation |
Compositions permettant de reguler la plage et/ou la vitesse de liberation du ph
|
|
WO2002002557A2
(en)
|
2000-06-30 |
2002-01-10 |
Neurogen Corporation |
2-phenylimidazo[1,2-a]pyridine derivatives: a new class of gaba brain receptor ligands
|
|
US20060142257A1
(en)
|
2001-01-19 |
2006-06-29 |
Eberhard Nieschlag |
Male contraceptive formulation comprising norethisterone
|
|
US6979682B2
(en)
|
2001-02-23 |
2005-12-27 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Platelet-activating factor antagonist inhibition of angiogenesis and tumor growth induced by basic fibroblast
|
|
UA76512C2
(en)
|
2001-09-04 |
2006-08-15 |
Boehringer Ingelheim Pharma |
Dihydropteridinones, a method for producing thereof and use thereof as medicament
|
|
US6806272B2
(en)
|
2001-09-04 |
2004-10-19 |
Boehringer Ingelheim Pharma Kg |
Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
|
|
US20030216758A1
(en)
|
2001-12-28 |
2003-11-20 |
Angiotech Pharmaceuticals, Inc. |
Coated surgical patches
|
|
GB0206215D0
(en)
|
2002-03-15 |
2002-05-01 |
Novartis Ag |
Organic compounds
|
|
JP3096299U
(ja)
|
2003-02-20 |
2003-09-12 |
宇輪工業股▲ふん▼有限公司 |
足踏み式健康器
|
|
US6861422B2
(en)
|
2003-02-26 |
2005-03-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
|
|
JP3876265B2
(ja)
|
2003-02-26 |
2007-01-31 |
ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト |
ジヒドロプテリジノン、その製造方法及び薬物形態での使用
|
|
GB0305929D0
(en)
|
2003-03-14 |
2003-04-23 |
Novartis Ag |
Organic compounds
|
|
WO2005002526A2
(en)
|
2003-07-01 |
2005-01-13 |
President And Fellows Of Harvard College |
Method and compositions for treatment of viral infections
|
|
US20070105839A1
(en)
|
2003-09-18 |
2007-05-10 |
Patricia Imbach |
2, 4-Di (phenylamino) pyrimidines useful in the treatment of proliferative disorders
|
|
EP1528056A1
(en)
|
2003-10-29 |
2005-05-04 |
Academisch Ziekenhuis bij de Universiteit van Amsterdam |
Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors
|
|
US7759485B2
(en)
|
2004-08-14 |
2010-07-20 |
Boehringer Ingelheim International Gmbh |
Process for the manufacture of dihydropteridinones
|
|
US20060058311A1
(en)
|
2004-08-14 |
2006-03-16 |
Boehringer Ingelheim International Gmbh |
Combinations for the treatment of diseases involving cell proliferation
|
|
US7728134B2
(en)
|
2004-08-14 |
2010-06-01 |
Boehringer Ingelheim International Gmbh |
Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
|
|
US20060074088A1
(en)
|
2004-08-14 |
2006-04-06 |
Boehringer Ingelheim International Gmbh |
Dihydropteridinones for the treatment of cancer diseases
|
|
US20060035903A1
(en)
|
2004-08-14 |
2006-02-16 |
Boehringer Ingelheim International Gmbh |
Storage stable perfusion solution for dihydropteridinones
|
|
WO2006021548A1
(de)
|
2004-08-27 |
2006-03-02 |
Boehringer Ingelheim International Gmbh |
Dihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel
|
|
GB0419161D0
(en)
|
2004-08-27 |
2004-09-29 |
Novartis Ag |
Organic compounds
|
|
CN1759834B
(zh)
|
2004-09-17 |
2010-06-23 |
中国医学科学院医药生物技术研究所 |
黄连素或其与辛伐他汀联合在制备用于预防或治疗与血脂有关疾病或症状的产品中用途
|
|
WO2006129623A1
(ja)
|
2005-05-30 |
2006-12-07 |
Mitsubishi Tanabe Pharma Corporation |
チエノトリアゾロジアゼピン化合物及びその医薬としての用途
|
|
BRPI0610876B8
(pt)
|
2005-06-08 |
2021-05-25 |
Rigel Pharmaceuticals Inc |
composto, formulação farmacêutica, e métodos de inibir uma atividade de uma jak cinase, e de inibir uma cascata de transdução de sinal em que jak3 cinase desempenha um papel
|
|
US20070203161A1
(en)
|
2006-02-24 |
2007-08-30 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the jak pathway
|
|
CA2617589A1
(en)
|
2005-08-03 |
2007-02-08 |
Boehringer Ingelheim International Gmbh |
Dihydropteridinones in the treatment of respiratory diseases
|
|
JP5191391B2
(ja)
|
2005-11-01 |
2013-05-08 |
ターゲジェン インコーポレーティッド |
キナーゼのビ−アリールメタ−ピリミジン阻害剤
|
|
US8133900B2
(en)
|
2005-11-01 |
2012-03-13 |
Targegen, Inc. |
Use of bi-aryl meta-pyrimidine inhibitors of kinases
|
|
US8604042B2
(en)
|
2005-11-01 |
2013-12-10 |
Targegen, Inc. |
Bi-aryl meta-pyrimidine inhibitors of kinases
|
|
EA200870117A1
(ru)
|
2005-12-23 |
2008-12-30 |
Смитклайн Бичам Корпорейшн |
Азаиндоловые ингибиторы аурора-киназ
|
|
JP4913157B2
(ja)
|
2006-01-17 |
2012-04-11 |
エフ．ホフマン−ラ ロシュ アーゲー |
ＧＡＢＡレセプター経由でのアルツハイマー病の処置に有用なアリール−イソオキサゾール−４−イル−イミダゾ［１，２−ａ］ピリジン誘導体
|
|
ZA200806871B
(en)
|
2006-02-14 |
2009-10-28 |
Vertex Pharma |
Dihydrodiazepines useful as inhibitors of protein kinases
|
|
US7622463B2
(en)
|
2006-02-14 |
2009-11-24 |
Vertex Pharmaceuticals Incorporated |
Dihydrodiazepines useful as inhibitors of protein kinases
|
|
US20070218135A1
(en)
|
2006-03-14 |
2007-09-20 |
Glenmark Pharmaceuticals Limited |
Sustained release matrix pharmaceutical composition
|
|
BRPI0711174A2
(pt)
|
2006-05-03 |
2011-08-23 |
Novartis Ag |
uso de compostos orgánicos
|
|
JP2009537500A
(ja)
|
2006-05-19 |
2009-10-29 |
アストラゼネカ アクチボラグ |
増殖抑制剤としてのジヒドロプテリジン化合物
|
|
WO2008009909A1
(en)
|
2006-07-17 |
2008-01-24 |
Astrazeneca Ab |
Pteridimones as modulators of polo-like kinase
|
|
MX337906B
(es)
|
2006-10-19 |
2016-03-28 |
Signal Pharm Llc |
Compuestos de heteroarilo, composiciones de los mismos, y su uso como inhibidores de proteina cinasas.
|
|
EA200900593A1
(ru)
|
2006-10-25 |
2010-06-30 |
Хрома Терапьютикс Лтд. |
Производные птеридина как ингибиторы polo-подобной киназы, применяющиеся при лечении рака
|
|
WO2008066887A2
(en)
|
2006-11-30 |
2008-06-05 |
Albert Einstein College Of Medicine Of Yeshiva University |
Small molecule inhibitors of bcl6
|
|
JP2008156311A
(ja)
|
2006-12-26 |
2008-07-10 |
Institute Of Physical & Chemical Research |
Ｂｒｄ２ブロモドメイン結合剤
|
|
ES2405655T3
(es)
|
2006-12-26 |
2013-05-31 |
Lantheus Medical Imaging, Inc. |
N-[3-bromo-4-(3-[18F]fluoropropoxi)-bencil]-guanidina para la formación de imágenes de la inervación cardíaca
|
|
AU2008228303B2
(en)
|
2007-03-22 |
2012-04-19 |
Takeda Pharmaceutical Company Limited |
Substituted pyrimidodiazepines useful as PLK1 inhibitors
|
|
WO2008137081A1
(en)
|
2007-05-02 |
2008-11-13 |
The Trustees Of Columbia University In The City Of New York |
Substituted ( 5, 6 ) -dihydronaphraalenyl compounds as reversible male contraceptives
|
|
KR20080107050A
(ko)
|
2007-06-05 |
2008-12-10 |
울산대학교 산학협력단 |
항-ｃｄ１３７ 단일클론 항체를 포함하는 만성이식편대숙주 질환의 예방 또는 치료용 약학적 조성물
|
|
AU2008287339A1
(en)
|
2007-08-15 |
2009-02-19 |
Vertex Pharmaceuticals Incorporated |
4-(9-(3, 3-difluorocyclopentyl) -5, 7, 7-trimethyl-6-oxo-6, 7, 8, 9-tetrahydro-5H-pyrimido [4, 5-b][1, 4] diazepin-2-ylamino)-3-methoxybenzamide Derivatives as Inhibitors of the Human Protein Kinases PLK1 to PLK4 for the Treatment of Proliferative Diseases
|
|
EP2205241B1
(en)
|
2007-09-25 |
2014-05-21 |
Takeda Pharmaceutical Company Limited |
Polo-like kinase inhibitors
|
|
PL2205603T3
(pl)
|
2007-09-28 |
2014-07-31 |
Cyclacel Ltd |
Pochodne pirymidyny jako inhibitory kinaz białkowych
|
|
US20090291938A1
(en)
|
2007-11-19 |
2009-11-26 |
Takeda Pharmaceutical Company Limited |
Polo-like kinase inhibitors
|
|
CA2710118A1
(en)
|
2007-12-20 |
2009-07-02 |
Cellzome Limited |
Sulfamides as zap-70 inhibitors
|
|
KR101600634B1
(ko)
|
2007-12-28 |
2016-03-07 |
미쓰비시 타나베 파마 코퍼레이션 |
항암제
|
|
US8318929B2
(en)
|
2008-03-10 |
2012-11-27 |
Janssen Pharmaceutica Nv |
4-aryl-2-anilino-pyrimidines
|
|
US20110098288A1
(en)
|
2008-03-11 |
2011-04-28 |
Jeremy Major |
Sulfonamides as zap-70 inhibitors
|
|
FR2928923B1
(fr)
|
2008-03-21 |
2010-04-23 |
Sanofi Aventis |
Derives polysubstitues de 2-heteroaryl-6-phenyl-imidazo °1,2-a!pyridines, leur preparation et leur application en therapeutiques
|
|
EP2112152A1
(en)
|
2008-04-22 |
2009-10-28 |
GPC Biotech AG |
Dihydropteridinones as Plk Inhibitors
|
|
EP2303889A1
(en)
|
2008-06-18 |
2011-04-06 |
F. Hoffmann-La Roche AG |
Halo-substituted pyrimidodiazepines as plkl inhibitors
|
|
WO2010015340A1
(en)
|
2008-08-06 |
2010-02-11 |
Bayer Schering Pharma Aktiengesellschaft |
Daa-pyridine as peripheral benzodiazepine receptor ligand for diagnostic imaging and pharmaceutical treatment
|
|
EP2334675B1
(en)
|
2008-09-16 |
2014-03-26 |
Csir |
Imidazopyridines and imidazopyrimidines as hiv-i reverse transcriptase inhibitors
|
|
ES2448567T3
(es)
|
2008-10-30 |
2014-03-14 |
Circomed Llc |
Derivados de la tienotriazoldiazepina activos en apo A
|
|
PT2356123E
(pt)
*
|
2008-11-13 |
2012-10-31 |
Hoffmann La Roche |
Espiro-5,6-di-hidro-4h-2,3,5,10b-tetra-azabenzo[ e]azulenos
|
|
EP3828185B1
(en)
|
2009-01-06 |
2024-11-20 |
Dana-Farber Cancer Institute, Inc. |
Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders
|
|
CN102341394B
(zh)
|
2009-01-23 |
2015-04-15 |
武田药品工业株式会社 |
聚(adp-核糖)聚合酶(parp)抑制剂
|
|
CN102020643A
(zh)
|
2009-09-22 |
2011-04-20 |
上海恒瑞医药有限公司 |
二氢喋啶酮类衍生物、其制备方法及其在医药上的应用
|
|
CN102548994A
(zh)
|
2009-09-25 |
2012-07-04 |
沃泰克斯药物股份有限公司 |
用于制备用作蛋白激酶抑制剂的嘧啶衍生物的方法
|
|
GB0919431D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
EP3050885B1
(en)
|
2009-11-05 |
2017-10-18 |
GlaxoSmithKline LLC |
Benzodiazepine bromodomain inhibitor
|
|
GB0919432D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Use
|
|
GB0919434D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB0919426D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB0919423D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
AU2010314395B2
(en)
|
2009-11-05 |
2015-04-09 |
Glaxosmithkline Llc |
Benzodiazepine bromodomain inhibitor
|
|
JP5841548B2
(ja)
|
2010-02-17 |
2016-01-13 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ジヒドロプテリジノン、その製造方法及び使用
|
|
PL2902030T3
(pl)
|
2010-05-14 |
2017-07-31 |
Dana-Farber Cancer Institute, Inc. |
Związki tienotriazolodiazepinowe do leczenia nowotworu
|
|
MX354217B
(es)
|
2010-05-14 |
2018-02-19 |
Dana Farber Cancer Inst Inc |
Composiciones y metodos para el tratamiento de leucemia.
|
|
CN103119160B
(zh)
|
2010-05-14 |
2016-06-01 |
达那-法伯癌症研究所 |
用于调节代谢的组合物和方法
|
|
JP5715241B2
(ja)
*
|
2010-05-14 |
2015-05-07 |
ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド |
新生物、炎症性疾患、およびその他の障害を治療するための組成物および方法
|
|
EP2571875A4
(en)
|
2010-05-14 |
2013-10-30 |
Dana Farber Cancer Inst Inc |
CONTRACEPTIVE COMPOSITIONS FOR MEN AND METHODS OF USE THEREOF
|
|
JP5844358B2
(ja)
*
|
2010-06-22 |
2016-01-13 |
グラクソスミスクライン エルエルシー |
ベンゾトリアゾロジアゼピン化合物を含むブロモドメイン阻害剤
|
|
US20120014979A1
(en)
|
2010-07-16 |
2012-01-19 |
Alexander Dent |
Use of bcl6 inhibitors for treating autoimmune diseases
|
|
US9358233B2
(en)
|
2010-11-29 |
2016-06-07 |
Boehringer Ingelheim International Gmbh |
Method for treating acute myeloid leukemia
|
|
WO2012075456A1
(en)
|
2010-12-02 |
2012-06-07 |
Constellation Pharmaceuticals |
Bromodomain inhibitors and uses thereof
|
|
AR084070A1
(es)
|
2010-12-02 |
2013-04-17 |
Constellation Pharmaceuticals Inc |
Inhibidores del bromodominio y usos de los mismos
|
|
AU2012220620A1
(en)
|
2011-02-23 |
2013-10-03 |
Icahn School Of Medicine At Mount Sinai |
Inhibitors of bromodomains as modulators of gene expression
|
|
WO2012118812A2
(en)
|
2011-02-28 |
2012-09-07 |
Epizyme, Inc. |
Substituted 6,5-fused bicyclic heteroaryl compounds
|
|
CN103458970A
(zh)
|
2011-03-07 |
2013-12-18 |
泰莱托恩基金会 |
Tfeb磷酸化抑制剂及其应用
|
|
GB201106799D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
|
WO2013033269A1
(en)
|
2011-08-29 |
2013-03-07 |
Coferon, Inc. |
Bioorthogonal monomers capable of dimerizing and targeting bromodomains and methods of using same
|
|
WO2013033268A2
(en)
|
2011-08-29 |
2013-03-07 |
Coferon, Inc. |
Bivalent bromodomain ligands, and methods of using same
|
|
DE102011082013A1
(de)
|
2011-09-01 |
2013-03-07 |
Bayer Pharma AG |
6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine
|
|
WO2013097052A1
(en)
|
2011-12-30 |
2013-07-04 |
Abbott Laboratories |
Bromodomain inhibitors
|
|
WO2013123521A1
(en)
|
2012-02-17 |
2013-08-22 |
Nexbio, Inc. |
Methods, Compounds and Compositions for Treatment of Parainfluenza Virus in Immunocompromised Patients
|
|
WO2013148197A1
(en)
|
2012-03-28 |
2013-10-03 |
The J. David Gladstone Institutes |
Compositions and methods for reactivating latent immunodeficiency virus
|
|
CA2878996C
(en)
|
2012-08-08 |
2021-09-14 |
Novomatic Ag |
Method of and system for tracking gaming activity
|
|
JP2015531365A
(ja)
|
2012-09-28 |
2015-11-02 |
オンコエシックス エスエー |
チエノトリアゾロジアゼピン化合物を含む医薬製剤
|
|
EP2917203B1
(en)
|
2012-11-02 |
2019-04-03 |
Dana-Farber Cancer Institute, Inc. |
Method for identifying myc inhibitors
|
|
CN105229002A
(zh)
|
2012-12-20 |
2016-01-06 |
拜耳医药股份有限公司 |
抑制bet蛋白的二氢吡啶并吡嗪酮
|
|
MX2015012158A
(es)
|
2013-03-11 |
2015-12-01 |
Abbvie Inc |
Inhibidores de bomodominio tetraciclicos fusionados.
|
|
US20140254659A1
(en)
|
2013-03-11 |
2014-09-11 |
Mediatek Inc. |
Video coding method using at least evaluated visual quality and related video coding apparatus
|
|
UY35395A
(es)
|
2013-03-12 |
2014-10-31 |
Abbvie Inc |
Inhibidores de bromodominios tetracíclicos
|
|
WO2014159392A1
(en)
|
2013-03-14 |
2014-10-02 |
Dana-Farber Cancer Institute, Inc. |
Bromodomain binding reagents and uses thereof
|
|
US9975896B2
(en)
|
2013-07-25 |
2018-05-22 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of transcription factors and uses thereof
|
|
AU2014323526B2
(en)
|
2013-09-19 |
2020-07-23 |
Dana-Farber Cancer Institute, Inc. |
Methods of BH3 profiling
|
|
WO2015081280A1
(en)
|
2013-11-26 |
2015-06-04 |
Coferon, Inc. |
Bromodomain ligands capable of dimerizing in an aqueous solution
|
|
WO2015081284A1
(en)
|
2013-11-26 |
2015-06-04 |
Coferon, Inc. |
Bivalent bromodomain ligands, and methods of using same
|
|
CN105980392A
(zh)
|
2013-12-10 |
2016-09-28 |
艾伯维公司 |
溴区结构域抑制剂
|
|
EP3099677A4
(en)
|
2014-01-31 |
2017-07-26 |
Dana-Farber Cancer Institute, Inc. |
Diaminopyrimidine benzenesulfone derivatives and uses thereof
|
|
US10793571B2
(en)
|
2014-01-31 |
2020-10-06 |
Dana-Farber Cancer Institute, Inc. |
Uses of diazepane derivatives
|
|
CN105940005A
(zh)
|
2014-01-31 |
2016-09-14 |
达纳-法伯癌症研究所股份有限公司 |
二氮杂环庚烷衍生物及其用途
|
|
MX2016009975A
(es)
|
2014-01-31 |
2016-10-31 |
Dana Farber Cancer Inst Inc |
Derivados de dihidropteridinona y sus usos.
|
|
WO2015129927A1
(en)
|
2014-02-26 |
2015-09-03 |
Kyorin Pharmaceutical Co., Ltd. |
Heterocyclic compounds
|
|
JP2017506666A
(ja)
|
2014-02-28 |
2017-03-09 |
テンシャ セラピューティクス，インコーポレイテッド |
高インスリン血症に関連した症状の処置
|
|
US20180228907A1
(en)
|
2014-04-14 |
2018-08-16 |
Arvinas, Inc. |
Cereblon ligands and bifunctional compounds comprising the same
|
|
CN106715437A
(zh)
|
2014-08-08 |
2017-05-24 |
达纳-法伯癌症研究所股份有限公司 |
二氮杂环庚烷衍生物及其用途
|
|
CN106793775B
(zh)
|
2014-08-08 |
2020-06-02 |
达纳-法伯癌症研究所股份有限公司 |
二氢碟啶酮衍生物及其用途
|
|
AU2015358334A1
(en)
|
2014-12-05 |
2017-06-08 |
Dana-Farber Cancer Institute, Inc. |
Bromodomain inhibitor as adjuvant in cancer immunotherapy
|
|
WO2016105518A1
(en)
*
|
2014-12-23 |
2016-06-30 |
Dana-Farber Cancer Institute, Inc. |
Methods to induce targeted protein degradation through bifunctional molecules
|
|
US9694084B2
(en)
|
2014-12-23 |
2017-07-04 |
Dana-Farber Cancer Institute, Inc. |
Methods to induce targeted protein degradation through bifunctional molecules
|
|
EP3270917A4
(en)
|
2015-03-18 |
2018-08-08 |
Arvinas, Inc. |
Compounds and methods for the enhanced degradation of targeted proteins
|
|
WO2016201370A1
(en)
|
2015-06-12 |
2016-12-15 |
Dana-Farber Cancer Institute, Inc. |
Combination therapy of transcription inhibitors and kinase inhibitors
|
|
WO2017007612A1
(en)
|
2015-07-07 |
2017-01-12 |
Dana-Farber Cancer Institute, Inc. |
Methods to induce targeted protein degradation through bifunctional molecules
|
|
WO2017024318A1
(en)
|
2015-08-06 |
2017-02-09 |
Dana-Farber Cancer Institute, Inc. |
Targeted protein degradation to attenuate adoptive t-cell therapy associated adverse inflammatory responses
|
|
US10772962B2
(en)
|
2015-08-19 |
2020-09-15 |
Arvinas Operations, Inc. |
Compounds and methods for the targeted degradation of bromodomain-containing proteins
|
|
CA2992889A1
(en)
|
2015-09-04 |
2017-03-09 |
F. Hoffmann-La Roche Ag |
Phenoxymethyl derivatives
|
|
JP6838052B2
(ja)
|
2015-09-09 |
2021-03-03 |
ジュビラント バイオシス リミテッドＪｕｂｉｌａｎｔ Ｂｉｏｓｙｓ Ｌｉｍｉｔｅｄ |
三環式縮合ピリジン−２−オン誘導体及びそれらのｂｒｄ４阻害剤としての用途
|
|
EP3347021A4
(en)
|
2015-09-11 |
2019-07-24 |
Dana-Farber Cancer Institute, Inc. |
CYANOTHIENOTRIAZOLDIAZEPINE AND USES THEREOF
|
|
RU2018112953A
(ru)
|
2015-09-11 |
2019-10-14 |
Дана-Фарбер Кэнсер Инститьют, Инк. |
Ацетамидтиенотриазолодиазепины и пути их применения
|
|
EP3347353B1
(en)
|
2015-09-11 |
2019-07-17 |
Boehringer Ingelheim International GmbH |
Pyrazolyl-substituted heteroaryls and their use as medicaments
|
|
MX2018006499A
(es)
|
2015-11-25 |
2018-08-01 |
Dana Farber Cancer Inst Inc |
Inhibidores de bromodominio bivalentes y usos de los mismos.
|
|
FI3380522T3
(fi)
|
2015-11-25 |
2024-01-16 |
Visterra Inc |
Vasta-ainemolekyylejä april-proteiinille ja niiden käyttöjä
|
|
EA201890949A1
(ru)
|
2015-11-25 |
2018-12-28 |
Джилид Аполло, Ллс |
СЛОЖНОЭФИРНЫЕ ИНГИБИТОРЫ АЦЕТИЛ-КоА-КАРБОКСИЛАЗЫ И ВАРИАНТЫ ИХ ПРИМЕНЕНИЯ
|
|
AU2016361412A1
(en)
|
2015-11-25 |
2018-05-24 |
Gilead Apollo, Llc |
Pyrazole ACC inhibitors and uses thereof
|
|
PL3380479T3
(pl)
|
2015-11-25 |
2023-05-08 |
Gilead Apollo, Llc |
Triazolowe inhibitory acc i ich zastosowania
|
|
BR112018009212B1
(pt)
|
2015-11-25 |
2022-06-14 |
Gilead Apollo, Llc |
Método para controlar patógenos fúngicos agrícolas
|
|
DK3888658T3
(da)
|
2015-11-25 |
2024-03-18 |
Effector Therapeutics Inc |
Eif4-a-inhiberende forbindelser og fremgangsmåder relateret dertil
|
|
WO2017094750A1
(ja)
|
2015-12-01 |
2017-06-08 |
日本農薬株式会社 |
３ｈ‐ピロロピリジン化合物若しくはそのｎ‐オキサイド、又はそれらの塩類及び該化合物を含有する農園芸用殺虫剤並びにその使用方法
|
|
CN109641874A
(zh)
|
2016-05-10 |
2019-04-16 |
C4医药公司 |
用于靶蛋白降解的c3-碳连接的戊二酰亚胺降解决定子体
|
|
CN109790143A
(zh)
|
2016-05-10 |
2019-05-21 |
C4医药公司 |
用于靶蛋白降解的胺连接的c3-戊二酰亚胺降解决定子体
|
|
WO2017201069A1
(en)
|
2016-05-18 |
2017-11-23 |
Biotheryx, Inc. |
Oxoindoline derivatives as protein function modulators
|
|
GB201608797D0
(en)
|
2016-05-19 |
2016-07-06 |
Ucb Biopharma Sprl |
Therapeutic use
|
|
WO2018064589A1
(en)
|
2016-09-29 |
2018-04-05 |
Dana-Farber Cancer Institute, Inc. |
Targeted protein degradation using a mutant e3 ubiquitin ligase
|